GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artgen Biotech PJSC (MIC:ABIO) » Definitions » Cyclically Adjusted PS Ratio

Artgen Biotech PJSC (MIC:ABIO) Cyclically Adjusted PS Ratio : 6.65 (As of Sep. 21, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Artgen Biotech PJSC Cyclically Adjusted PS Ratio?

As of today (2024-09-21), Artgen Biotech PJSC's current share price is ₽75.42. Artgen Biotech PJSC's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec22 was ₽11.34. Artgen Biotech PJSC's Cyclically Adjusted PS Ratio for today is 6.65.

The historical rank and industry rank for Artgen Biotech PJSC's Cyclically Adjusted PS Ratio or its related term are showing as below:

MIC:ABIO' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.3   Med: 4.27   Max: 16.26
Current: 6.53

During the past 13 years, Artgen Biotech PJSC's highest Cyclically Adjusted PS Ratio was 16.26. The lowest was 1.30. And the median was 4.27.

MIC:ABIO's Cyclically Adjusted PS Ratio is ranked worse than
56.47% of 464 companies
in the Biotechnology industry
Industry Median: 5.355 vs MIC:ABIO: 6.53

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Artgen Biotech PJSC's adjusted revenue per share data of for the fiscal year that ended in Dec22 was ₽13.081. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₽11.34 for the trailing ten years ended in Dec22.

Shiller PE for Stocks: The True Measure of Stock Valuation


Artgen Biotech PJSC Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Artgen Biotech PJSC's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artgen Biotech PJSC Cyclically Adjusted PS Ratio Chart

Artgen Biotech PJSC Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.26 1.86 4.66 11.88 5.47

Artgen Biotech PJSC Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 11.88 - 5.47 -

Competitive Comparison of Artgen Biotech PJSC's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Artgen Biotech PJSC's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Artgen Biotech PJSC's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Artgen Biotech PJSC's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Artgen Biotech PJSC's Cyclically Adjusted PS Ratio falls into.



Artgen Biotech PJSC Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Artgen Biotech PJSC's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=75.42/11.34
=6.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artgen Biotech PJSC's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Dec22 is calculated as:

For example, Artgen Biotech PJSC's adjusted Revenue per Share data for the fiscal year that ended in Dec22 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec22 (Change)*Current CPI (Dec22)
=13.081/231.9000*231.9000
=13.081

Current CPI (Dec22) = 231.9000.

Artgen Biotech PJSC Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201312 5.597 124.900 10.392
201412 4.792 139.000 7.995
201512 4.144 157.000 6.121
201612 5.205 165.400 7.298
201712 6.593 169.600 9.015
201812 8.596 176.800 11.275
201912 11.141 182.200 14.180
202012 14.454 191.100 17.540
202112 14.760 207.200 16.520
202212 13.081 231.900 13.081

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Artgen Biotech PJSC  (MIC:ABIO) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Artgen Biotech PJSC Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Artgen Biotech PJSC's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Artgen Biotech PJSC Business Description

Traded in Other Exchanges
N/A
Address
Prospect of the 60th Anniversary, Moscow, RUS, 117036
Artgen Biotech PJSC formerly Human Stem Cells Institute PJSC is a biotechnology company. It is engaged in the drug discovery, research and development and marketing of proprietary products and services in the field of regenerative medicine, bio-insurance, medical genetics, including reproductive genetics, gene therapy, and biopharmaceutics. The company has developed Neovasculgen, which is a gene therapy drug for the treatment of Peripheral Arterial Disease, including Critical Limb Ischemia and also develops SPRS therapy which entails the use of autologous dermal fibroblasts to repair skin damage due to aging and other structural changes.